Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH) antagonists

Journal of Medicinal Chemistry

Volumn 43, Issue 5, 2000, Pages 784-796

  Rivier, Jean E ^c   Struthers, R Scott ^b   Porter, John ^a   Lahrichi, Sabine L ^a   Jiang, Guangcheng ^a   Cervini, Laura A ^a   Ibea, Michel ^a   Kirby, Dean A ^a   Koerber, Steven C ^a   Rivier, Catherine L ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN ANTAGONIST; GONADORELIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; COMPETITIVE INHIBITION; DRUG CONFORMATION; DRUG DESIGN; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FEMALE; NONHUMAN; OVULATION INHIBITION; RAT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MODELS, MOLECULAR; OVULATION; PEPTIDES, CYCLIC; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034624708     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990115h     Document Type: Article

References (59)

1. Rivier, J.; Kupryszewski, G.; Varga, J.; Porter, J.; Rivier, C.; Perrin, M.; Hagler, A.; Struthers, S.; Corrigan, A.; Vale, W. Design of potent cyclic gonadotropin releasing hormone (GnRH) antagonists. J. Med. Chem. 1988, 31, 677-682.
2. Dutta, A. S.; Gormley, J. J.; McLachlan, P. F.; Woodburn, J. R. Conformationally restrained cyclic peptides as antagonists of luteinizing hormone-releasing hormone. Biochem. Biophys. Res. Commun. 1989, 159, 1114-1120.
3. Matsuo, H.; Baba, Y.; Nair, R. M.; Arimura, A.; Schally, A. V. Structure of the porcine LH-and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem. Biophys. Res. Commun. 1971, 43, 1334-1339.
4. Burgus, R.; Butcher, M.; Amoss, M.; Ling, N.; Monahan, M.; Rivier, J.; Fellows, R.; Blackwell, R.; Vale, W.; Guillemin, R. Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF). Proc. Natl. Acad. Sci. U.S.A. 1972, 69, 278-282.
5. Rivier, J.; Rivier, J.; Vale, W. Anti-reproductive effects of potent GnRH antagonist in the male rat. Science 1980, 210, 93-95.
6. Rivier, C.; Rivier, J.; Vale, W. Anti-reproductive effects of a potent GnRH antagonist in the female rat. Endocrinology 1981, 108, 1425-1430.
7. Karten, M. J.; Rivier, J. E. Gonadotropin-releasing hormone analogue design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective. Endocrine Rev. 1986, 7, 44-66.
8. Pavlou, S. N.; Brewer, K.; Farley, M. G.; Lindner, J.; Bastias, M-C.; Rogers, B. J.; Rivier, J. E.; Swift, L. L.; Vale, W. W.; Conn, P. M.; Herbert, C. M. Combined administration of a GnRH antagonist and testosterone in men induces reversible azoospermia without loss of libido. J. Clin. Endocrinol. Metab. 1991, 73, 1360-1369.
9. Bagatell, C. J.; Matsumoto, A. M.; Christensen, R. B.; Rivier, J. E.; Bremner, W. J. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens. J. Clin. Endocrinol. Metab. 1993, 77, 427-432.
10. Swerdloff, R. S.; Bagatell, C. J.; Wang, C.; Anawalt, B. D.; Berman, N.; Steiner, B.; Bremner, W. J. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone. J. Clin. Endocrinol. Metab. 1998, 83, 3527-3533.
11. Ditkoff, E. C.; Cassidenti, D. L.; Paulson, R. J.; Sauer, M. V.; Wellington, L. P.; Rivier, J.; Yen, S. S. C.; Lobo, R. A. The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. Am. J. Obstet. Gynecol. 1992, 165, 1811-1817.
12. Kettel, L. M.; Murphy, A. A.; Morales, A. J.; Rivier, J.; Vale, W. W.; Yen, S. S. C. Rapid regression of uterine leiomyoma in response to long-term daily administration of GnRH antagonist. Fertil. Steril. 1993, 60, 642-646.
13. Perrin, M. H.; Haas, Y.; Rivier, J. E.; Vale, W. W. GnRH binding to rat anterior pituitary membrane homogenates: Comparison of antagonists and agonists using radiolabeled antagonist and agonist. Mol. Pharmacol. 1983, 23, 44-51.
14. Rizo, J.; Koerber, S. C.; Bienstock, R. J.; Rivier, J.; Hagler, A. T.; Gierasch, L. M. Conformational analysis of a highly potent, constrained gonadotropin-releasing hormone antagonist. I. Nuclear magnetic resonance. J. Am. Chem. Soc. 1992, 114, 2852-2859.
15. Rizo, J.; Koerber, S. C.; Bienstock, R. J.; Rivier, J.; Gierasch, L. M.; Hagler, A. T. Conformational analysis of a highly potent, constrained gonadotropin-releasing hormone antagonist. II. Molecular Dynamics simulations. J. Am. Chem. Soc. 1992, 114, 2860-2871.
16. Rizo, J.; Sutton, R. B.; Breslau, J.; Koerber, S. C.; Porter, J.; Hagler, A. T.; Rivier, J.; Gierasch, L. M. A novel conformation in a highly potent, constrained gonadotropin releasing hormone antagonist. J. Am. Chem. Soc. 1996, 118, 970-976.
17. Bienstock, R. J.; Rizo, J.; Koerber, S. C.; Rivier, J. E.; Hagler, A. T.; Gierasch, L. M. Conformational analysis of a highly potent dicyclic gonadotropin-releasing hormone antagonist by nuclear magnetic resonance and molecular dynamics. J. Med. Chem. 1993, 36, 3265-3273.
18. Rivier, J.; Vale, W.; Burgus, R.; Ling, N.; Amoss, M.; Blackwell, R.; Guillemin, R. Synthetic luteinizing hormone releasing factor analogues Series of short chain amide LRF homologues converging to the amino terminus. J. Med. Chem. 1973, 16, 545-549.
19. Rivier, J. E.; Jiang, G.; Porter, J.; Hoeger, C.; Craig, A. G.; Corrigan, A. Z.; Vale, W. W.; Rivier, C. L. GnRH antagonists: novel members of the azaline B family. J. Med. Chem. 1995, 38, 2649-2662.
20. Jiang, G.-C.; Simon, L.; Rivier, J. E. Orthogonally protected N-methyl-substituted α-aminoglycines. Protein Pept. Lett. 1996, 3, 219-224.
21. Felix, A. M.; Heimer, E. P.; Wang, C. T.; Lambros, T. J.; Fournier, A.; Mowles, T. F.; Maines, S.; Campbell, R. M.; Wegrzynski, B. B.; Toome, V.; Fry, D.; Madison, V. S. Synthesis, biological activity and conformational analysis of cyclic GRF analogues. Int. J. Pept. Protein Res. 1988, 32, 441-454.
22. Rivier, J. Use of trialkylammonium phosphate (TAAP) buffers in reverse phase HPLC for high resolution and high recovery of peptides and proteins. J. Liq. Chromatogr. 1978, 1, 343-367.
23. Hoeger, C. A.; Galyean, R. F.; Boublik, J.; McClintock, R. A.; Rivier, J. E. Preparative reversed phase high performance liquid chromatography. II. Effects of buffer pH on the purification of synthetic peptides. Biochromatography 1987, 2, 134-142.
24. Porter, J.; Dykert, J.; Rivier, J. Synthesis, resolution and characterization of ring substituted phenylalanines and tryptophans. Int. J. Pept. Protein Res. 1987, 30, 13-21.
25. Corbin, A.; Beattie, C. W. Inhibition of the pre-ovulatory proestrous gonadotropin surge, ovulation and pregnancy with a peptide analogue of luteinizing hormone releasing hormone. Endocr. Res. Commun. 1975, 2, 1-23.
26. Karten, M. J. An overview of GnRH antagonists development: Two decades of progress. In Modes of Action of GnRH and GnRH Analogues; Crowley, W. F., Jr., Conn, P. M., Eds.; Springer-Verlag: New York, 1992; pp 277-297.
27. Grant, G.; Vale, W. W. Pituitary receptor binding assay of hypothalamic releasing factors. In Methods in Enzymology, Hormones and Cyclic Nucleotides; O'Malley, B. W., Hardman, J. G., Eds.; Academic Press: New York, 1974; Vol. 37, pp 213-219.
28. Vale, W.; Grant, G. In vitro pituitary hormone secretion for hypophysiotropic substances. In Methods in Enzymology, Hormones and Cyclic Nucleotides; O'Malley, B. W., Hardman, J. G., Eds.; Academic Press: New York, 1974; Vol. 37, pp 82-93.
29. Campen, C. A.; Lai, M. T.; Kraft, P.; Kirchner, T.; Phillips, A.; Hahn, D. W.; Rivier, J. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B". Biochem. Pharmacol. 1995, 49, 1313-1321.
30. Jiang, G.; Miller, C.; Koerber, S. C.; Porter, J.; Craig, A. G.; Bhattacharjee, S.; Kraft, P.; Bums, T. P.; Campen, C. A.; Rivier, C. L.; Rivier, J. E. Betidamino acid scan of the GnRH antagonist Acyline. J. Med. Chem. 1997, 40, 3739-3748.
31. Koerber, S. C.; Rizo, J.; Struthers, R. S.; Rivier, J. E. Consensus bioactive conformation of cyclic GnRH antagonists defined by NMR and molecular modeling. J. Med. Chem. 2000, 43, 819-828.
32. Rivier, C.; Rivier, J.; Vale, W. GnRH antagonists: Physiologic and contraceptive applications in the female rat. In LHRH Peptides as Female and Male Contraceptives: Zatuchni, G. I., Shelton, J. D., Sciarra, J. J., Eds.; Harper and Row: Philadelphia, PA, 1981; pp 140-150.
33. Rivier, J.; Kupryszewski, G.; Theobald, P.; Hoeger, C.; Porter, J.; Perrin, M.; Corrigan, A.; Struthers, S.; Koerber, S.; Hagler, A.; Vale, W.; Rivier, C. Two distinct approaches for the design of potent GnRH antagonists. In The Basic Science of GnRH Analogues; Lunenfeld, B., Eds.; Parthenon Publishing: Camforth, Lancaster, U.K., 1991; pp 123-135.
34. Struthers, R. S.; Tanaka, G.; Koerber, S. C.; Solmajer, T.; Baniak, E. L.; Gierasch, L. M.; Vale, W. W.; Rivier, J.; Hagler, A. T. Design of biologically active, conformationally constrained GnRH antagonists. Proteins 1990, 8, 295-304.
35. Struthers, R. S.; Hagler, A. T.; Rivier, J. Theoretical stimulation of conformation, energetics, and dynamics. In Conformationally Directed Drug Design: Peptides and Nucleic Acids as Templates or Targets; Vida, J. A., Gordon, M., Eds.; American Chemical Society: Washington, DC, 1984; pp 239-261.
36. Baniak, E. L., II; Rivier, J. E.; Struthers, R. S.; Hagler, A. T.; Gierasch, L. M. Nuclear magnetic resonance analysis and conformational characterization of a cyclic decapeptide antagonist of gonadotropin-releasing hormone. Biochemistry 1987, 26, 2642-2656.
37. Rivier, J.; Rivier, C.; Perrin, M.; Porter, J.; Vale, W. LHRH analogues as antiovulatory agents. In LHRH and Its Analogues - Contraceptive and Therapeutic Applications. Advances in Reproduction; Vickery, B. H., Nestor, J. J., Jr., Hafez, E. S. E., Eds.; MTP Press: Lancaster, Boston, The Hague, 1984; pp 11-22.
38. Coy, D. H.; Coy, E. J.; Schally, A. V. Luteinizing hormone releasing hormone. Solid-phase synthesis of a 5-phenylalanine analog possessing high biological activity. J. Med. Chem. 1973, 16, 83-84.
39. Yanaihara, N.; Hashimoto, T.; Yanaihara, C.; Tsuji, K.; Kenmochi, Y.; Ashizawa, F.; Kaneko, T.; Oka, H.; Saito, S.; Arimura, A.; Schally, A. V. Synthesis and biological evaluation of analogues of luteinizing hormone-releasing hormone (LH-RH) modified in position 2, 3, 4 or 5. Biochem. Biophys. Res. Commun. 1973, 52, 64-73.
40. Arnold, W.; Flouret, G.; Morgan, R.; Rippel, R.; White, W. Synthesis and biological activity of some analogues of the gonadotropin releasing hormone. J. Med. Chem. 1974, 17, 314-319.
41. 8 - analogues and conformation-sequence-activity relationships. Biochem. Biophys. Res. Commun. 1972, 47, 727.
42. Miyamoto, K.; Hasegawa, Y.; Nomura, M.; Igarashi, M.; Kangawa, K.; Matsuo, H. Identification of the second gonadotropin-releasing hormone in chicken hypothalamus: evidence that gonadotropin secretion is probably controlled by two distinct gonadotropin-releasing hormones in avian species. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 3874.
43. Powell, J. F. F.; Reska-Skinner, S. M.; Prakash, O. M.; Fischer, W. H.; Park, M.; Rivier, J. E.; Craig, A. G.; Mackie, G. O.; Sherwood, N. M. Two new forms of gonadotropin-releasing hormone in a protochordate and the evolutionary implications. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 10461-10464.
44. Rivier, J.; Varga, J.; Porter, J.; Perrin, M.; Haas, Y.; Corrigan, A.; Rivier, C.; Vale, W.; Struthers, S.; Hagler, A. Potent conformationally constrained analogues of GnRH. In Peptides: Structure and Function; Deber, C. M., Hruby, V. J., Kopple, K. D., Eds.; Pierce Chemical Company, Rockford, IL, 1986; pp 541-544.
45. Paul, P. K. C.; Dauber-Osguthorpe, P.; M. M. Campbell; Osguthorpe, D. J. A novel β-turn in an LHRH antagonist: a combined conformational search and molecular dynamics study. Biochem. Biophys. Res. Commun. 1989, 165, 1051-1058.
46. Coy, D. H.; Horvath, A.; Nekola, M. V.; Coy, E. J.; Erchegyi, J.; Schally, A. V. Peptide antagonists of LH-RH: large increased in antiovulatory activities produced by basic D-amino acids in the six position. Endocrinology 1982, 110, 1445-1447.
47. Bajusz, S.; Kovacs, M.; Gazdag, M.; Bokser, L.; Karashima, T.; Csernus, V. J.; Janaky, T.; Guoth, J.; Schally, A. V. Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 1637-1641.
48. Rivier, J.; Porter, J.; Rivier, C.; Perrin, M.; Corrigan, A. Z.; Hook, W. A.; Siraganian, R. P.; Vale, W. W. New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro. J. Med. Chem. 1986, 29, 1846-1851.
49. Miller, C.; Rivier, J. Analysis of synthetic peptides by capillary zone electrophoresis in organic/aqueous buffers. J. Pept. Res. 1998, 51, 444-451.
50. Märki, W.; Spiess, J.; Taché, Y.; Brown, M.; Rivier, J. E. Total solid-phase synthesis of porcine gut gastrin releasing peptide (GRP), a mammalian bombesin. J. Am. Chem. Soc. 1981, 103, 3178-3185.
51. Stewart, J. M.; Young, J. D. Solid-Phase Peptide Synthesis. Pierce Chemical Co.: Rockford, IL, 1969.
52. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 1970, 34, 595-598.
53. Felix, A. M.; Wang, C.-T.; Heimer, E. P.; Fournier, A. Applications of BOP reagent in solid-phase synthesis. II. Solid-phase side-chain to side-chain cyclizations using BOP reagent. Int. J. Pept. Protein Res. 1988, 31, 231-238.
54. Miller, C.; Rivier, J. Peptide chemistry: Development of high-performance liquid chromatography and capillary zone electrophoresis. Biopolymers 1996, 40, 265-317.
55. Eidne, K. A.; Sellar, R. E.; Couper, G.; Anderson, L.; Taylor, P. L. Molecular cloning and characterisation of the rat pituitary gonadotropin-releasing hormone (GnRH) receptor. Mol. Cell. Endocrinol. 1992, 90, R5-R9.
56. Kaiser, U. B.; Zhao, D.; Cardone, G. R.; Chin, W. W. Isolation and characterization of cDNAs encoding the rat pituitary gonadotropin-releasing hormone receptor. Biochem. Biophys. Res. Commun. 1992, 189, 1645-1652.
57. Perrin, M. H.; Bilezikjian, L. M.; Hoeger, C.; Donaldson, C. J.; Rivier, J. E.; Haas, Y.; Vale, W. W. Molecular and functional characterization of GnRH receptors cloned from rat pituitary and a mouse pituitary tumor cell line. Biochem. Biophys. Res. Commun. 1993, 191, 1139-1144.
58. Maple, J.; Dinur, U.; Hagler, A. T. Derivation of force fields for molecular mechanics and dynamics from Ab Initio energy surfaces. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 5350-5354.
59. Maple, J. R.; Thacher, T. S.; Dinur, U.; Hagler, A. T. Biosym force field research results in new techniques for the extraction of inter-and intramolecular forces. Chem. Des. Auto. News 1990, 5, 5-10.